Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. cut its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 25.7% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 16,863 shares of the company’s stock after selling 5,842 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Doximity were worth $735,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. William Blair Investment Management LLC boosted its stake in shares of Doximity by 15.8% in the second quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company’s stock valued at $179,122,000 after purchasing an additional 873,682 shares during the period. Clearbridge Investments LLC boosted its position in Doximity by 7.1% in the 2nd quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company’s stock valued at $163,709,000 after buying an additional 387,200 shares during the last quarter. Swedbank AB acquired a new stake in shares of Doximity during the first quarter valued at about $91,673,000. Janus Henderson Group PLC grew its stake in shares of Doximity by 33.5% during the first quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company’s stock valued at $66,594,000 after acquiring an additional 621,590 shares in the last quarter. Finally, Capital World Investors increased its position in shares of Doximity by 250.7% during the first quarter. Capital World Investors now owns 1,714,707 shares of the company’s stock worth $46,143,000 after acquiring an additional 1,225,707 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Trading Up 5.7 %

DOCS opened at $52.24 on Tuesday. The business’s 50 day moving average is $43.71 and its 200-day moving average is $34.45. The stock has a market cap of $9.75 billion, a PE ratio of 60.05, a price-to-earnings-growth ratio of 4.09 and a beta of 1.30. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $61.75.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on DOCS. Canaccord Genuity Group reaffirmed a “hold” rating and issued a $60.00 target price (up from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. Needham & Company LLC raised shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a report on Friday, August 9th. Raymond James reissued an “outperform” rating and set a $65.00 price objective (up from $37.00) on shares of Doximity in a report on Friday, November 8th. Morgan Stanley upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $33.00 to $53.00 in a research note on Thursday, November 14th. Finally, Wells Fargo & Company upgraded Doximity from an “underweight” rating to an “equal weight” rating and lifted their price target for the stock from $19.00 to $41.00 in a research note on Friday, November 8th. Eleven research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $51.07.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.